Given the previous correlations between disease severity and IL-17A levels during Mycoplasma infection, and the elevated IL-17A in LAMPs-vaccinated/Mp-challenged animals, we wished to determine the cellular sources of IL-17A in our model. This evidence concerns the gene IL17A and Mycoplasmoides infection.